Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 7, 2022

View Archived Issues

Modulating CYTOR promotes myogenesis in aging

TGFBR3L modulates FSH activity and fertility

Hemagglutinin anchor epitope unveiled as a target of broadly neutralizing antibodies

Compact cell classifiers packaged into AAV vectors for precision tumor cell targeting

MRSA superbug has prickly origins

French researchers patent new antibacterial compounds

Janssen Pharmaceutica discloses Mcl-1 inhibitors

Anaxis Pharma identifies new RIPK1 and/or MLKL inhibitors

Chinese researchers describe new GLP-1 receptor agonists

Life Biosciences to accelerate R&D activities on aging-related programs

Pfizer and BioNTech collaborate on mRNA-based vaccine to prevent shingles

Discovery of novel bergenin derivatives as immunosuppressive agents

Wigen Biomedicine Technology synthesizes new Wee1 inhibitors

RBT-0813 shown to neutralize Omicron and Delta variants of SARS-CoV-2 in live virus studies

Cystic Fibrosis Foundation award supports development of Peptilogics' PLG-0301 and PLG-0206

SalioGen obtains funding to advance research into genetic therapy for cystic fibrosis

Series A financing at ONK Therapeutics to support NK cell therapies through IND-enabling studies

Biomea's menin inhibitor BMF-219 normalizes glucose levels in animal models of type 2 diabetes

JUVA-019 enters preclinical development for inflammatory disease

LA-PAMAM/pmiR-218 polyplex as potential targeted gene therapy against HCC

Enanta expands respiratory virology program with EDP-323 for RSV

Regulating fibrin-neutrophil interaction for controlling periodontitis

Unity Biotechnology eyes IND-enabling studies with pipeline programs in 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...